Table 2. Univariable and Multivariable logistic regression analysis for receiving SRS.
| Variables | Univariable analysis | P-value | Multivariable analysis | P-value | |
|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | ||||
| Age | 1.01 (0.99–1.01) | 0.69 | … | ||
| Sex | Male | Ref | Ref | ||
| Female | 1.03 (0.92–1.15) | 0.62 | … | ||
| Race | White | Ref | Ref | ||
| Black | 1.08 (0.90–1.31) | 0.41 | … | ||
| Other | 0.94 (0.71–1.26) | 0.69 | … | ||
| Education | >=13% NHSD | 0.91 (0.81–1.02) | 0.11 | NS | 0.22 |
| <13% NHSD | Ref | Ref | |||
| Income | >=$35,000 | Ref | Ref | ||
| <35,000 | 1.02 (0.91–1.14) | 0.77 | 0.88 (0.72–1.08) | 0.23 | |
| Place of Living | Urban | Ref | Ref | ||
| Rural | 1.55 (0.94–2.57) | 0.09 | 1.57 (0.94–2.61) | 0.09 | |
| Hospital Type | Academic | Ref | Ref | ||
| Community | 0.97 (0.87–1.09) | 0.63 | … | ||
| Insurance Status | Yes | Ref | Ref | ||
| No | 1.10 (0.78–1.54) | 0.59 | … | ||
| Charlson/Deyo Score | 0 | Ref | Ref | ||
| 1 | 0.84 (0.74–0.96) | 0.01 | 0.84 (0.73–0.96) | 0.01 | |
| >=2 | 0.768 (0.640–0.922) | 0.01 | 0.78 (0.65–0.94) | 0.01 | |
| Chemotherapy | Yes | Ref | Ref | ||
| No | 0.77 (0.68–0.87) | <0.01 | 0.82 (0.72–0.94) | <0.01 | |
| Primary Cancer | Breast | 0.71 (0.45–1.13) | 0.15 | 0.70 (0.44–1.13) | 0.15 |
| NSCLC | 0.91 (0.67–1.25) | 0.58 | 0.90 (0.65–1.25) | 0.52 | |
| SCLC | 0.95 (0.60–1.50) | 0.83 | 0.95 (0.59–1.53) | 0.84 | |
| Other Lung | 0.62 (0.41–0.95) | 0.03 | 0.63 (0.41–0.97) | 0.04 | |
| Melanoma | 0.61 (0.42–0.89) | 0.01 | 0.65 (0.44–0.96) | 0.03 | |
| CRC | 0.50 (0.28–0.91) | 0.02 | 0.50 (0.27–0.92) | 0.03 | |
| Renal Cell | Ref | Ref | |||
| Year of Diagnosis | 2010–2013 | 1.38 (1.23–1.54) | <0.01 | 1.36 (1.21–1.51) | <0.01 |
| 2014–2015 | Ref | Ref |
Notes.
- Trt
- treatment treatment
- NHSD
- no high school degree